196 related articles for article (PubMed ID: 35982322)
21. Extensive Molecular and Clinical Heterogeneity in Patients With Histologically Diagnosed CNS-PNET Treated as a Single Entity: A Report From the Children's Oncology Group Randomized ACNS0332 Trial.
Hwang EI; Kool M; Burger PC; Capper D; Chavez L; Brabetz S; Williams-Hughes C; Billups C; Heier L; Jaju A; Michalski J; Li Y; Leary S; Zhou T; von Deimling A; Jones DTW; Fouladi M; Pollack IF; Gajjar A; Packer RJ; Pfister SM; Olson JM
J Clin Oncol; 2018 Oct; 36(34):JCO2017764720. PubMed ID: 30332335
[TBL] [Abstract][Full Text] [Related]
22. CNS high-grade neuroepithelial tumor with BCOR internal tandem duplication: a comparison with its counterparts in the kidney and soft tissue.
Yoshida Y; Nobusawa S; Nakata S; Nakada M; Arakawa Y; Mineharu Y; Sugita Y; Yoshioka T; Araki A; Sato Y; Takeshima H; Okada M; Nishi A; Yamazaki T; Kohashi K; Oda Y; Hirato J; Yokoo H
Brain Pathol; 2018 Sep; 28(5):710-720. PubMed ID: 29226988
[TBL] [Abstract][Full Text] [Related]
23. Treatment outcomes and late toxicities in patients with embryonal central nervous system tumors.
Odagiri K; Omura M; Hata M; Aida N; Niwa T; Goto H; Ito S; Adachi M; Yoshida H; Yuki H; Inoue T
Radiat Oncol; 2014 Sep; 9():201. PubMed ID: 25209395
[TBL] [Abstract][Full Text] [Related]
24. Survival after chemotherapy and stem cell transplant followed by delayed craniospinal irradiation is comparable to upfront craniospinal irradiation in pediatric embryonal brain tumor patients.
Raleigh DR; Tomlin B; Buono BD; Roddy E; Sear K; Byer L; Felton E; Banerjee A; Torkildson J; Samuel D; Horn B; Braunstein SE; Haas-Kogan DA; Mueller S
J Neurooncol; 2017 Jan; 131(2):359-368. PubMed ID: 27778212
[TBL] [Abstract][Full Text] [Related]
25. Spectrum of paired-like homeobox 2b immunoexpression in pediatric brain tumors with embryonal morphology.
Alturkustani M; Walker AD; Tran I; Snuderl M; Cotter JA
Pathol Int; 2022 Aug; 72(8):402-410. PubMed ID: 35763016
[TBL] [Abstract][Full Text] [Related]
26. Molecular pathological insights reveal a high number of unfavorable risk patients among children treated for medulloblastoma and CNS-PNET in Oslo 2005-2017.
Niehusmann P; Stensvold E; Leske H; Pietsch T; Goschzik T; Gielen GH; Due-Tønnessen B; Frič R; Nilssen Y; Brandal P
Pediatr Blood Cancer; 2022 Sep; 69(9):e29736. PubMed ID: 35570402
[TBL] [Abstract][Full Text] [Related]
27. Germ cell tumors with neuroglial differentiation do not show molecular features akin to their central nervous system counterpart: experience from extra-gynecological sites.
Chatterjee D; Gude G; Samujh R; Mete UK; Radotra B
Virchows Arch; 2022 Aug; 481(2):213-221. PubMed ID: 35678876
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological and molecular characterization of a case classified by DNA‑methylation profiling as "CNS embryonal tumor with BRD4-LEUTX fusion".
Lebrun L; Allard-Demoustiez S; Gilis N; Van Campenhout C; Rodesch M; Roman C; Calò P; Lolli V; David P; Fricx C; De Witte O; Escande F; Maurage CA; Salmon I
Acta Neuropathol Commun; 2023 Mar; 11(1):46. PubMed ID: 36934287
[TBL] [Abstract][Full Text] [Related]
29. Relevance of Molecular Groups in Children with Newly Diagnosed Atypical Teratoid Rhabdoid Tumor: Results from Prospective St. Jude Multi-institutional Trials.
Upadhyaya SA; Robinson GW; Onar-Thomas A; Orr BA; Johann P; Wu G; Billups CA; Tatevossian RG; Dhanda SK; Srinivasan A; Broniscer A; Qaddoumi I; Vinitsky A; Armstrong GT; Bendel AE; Hassall T; Partap S; Fisher PG; Crawford JR; Chintagumpala M; Bouffet E; Gururangan S; Mostafavi R; Sanders RP; Klimo P; Patay Z; Indelicato DJ; Nichols KE; Boop FA; Merchant TE; Kool M; Ellison DW; Gajjar A
Clin Cancer Res; 2021 May; 27(10):2879-2889. PubMed ID: 33737307
[TBL] [Abstract][Full Text] [Related]
30. Vorinostat and isotretinoin with chemotherapy in young children with embryonal brain tumors: A report from the Pediatric Brain Tumor Consortium (PBTC-026).
Leary SES; Kilburn L; Geyer JR; Kocak M; Huang J; Smith KS; Hadley J; Ermoian R; MacDonald TJ; Goldman S; Phillips P; Young Poussaint T; Olson JM; Ellison DW; Dunkel IJ; Fouladi M; Onar-Thomas A; Northcott PA
Neuro Oncol; 2022 Jul; 24(7):1178-1190. PubMed ID: 34935967
[TBL] [Abstract][Full Text] [Related]
31. Concurrent cyclophosphamide and craniospinal radiotherapy for pediatric high-risk embryonal brain tumors.
Campen CJ; Dearlove J; Partap S; Murphy P; Gibbs IC; Dahl GV; Fisher PG
J Neurooncol; 2012 Nov; 110(2):287-91. PubMed ID: 22941430
[TBL] [Abstract][Full Text] [Related]
32. Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy.
Tekautz TM; Fuller CE; Blaney S; Fouladi M; Broniscer A; Merchant TE; Krasin M; Dalton J; Hale G; Kun LE; Wallace D; Gilbertson RJ; Gajjar A
J Clin Oncol; 2005 Mar; 23(7):1491-9. PubMed ID: 15735125
[TBL] [Abstract][Full Text] [Related]
33. Extracranial extra-CNS spread of embryonal tumor with multilayered rosettes (ETMR): case series and systematic review.
Shah AH; Khatib Z; Niazi T
Childs Nerv Syst; 2018 Apr; 34(4):649-654. PubMed ID: 29177676
[TBL] [Abstract][Full Text] [Related]
34. Children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor in Norway from 1974 through 2013: Unexplainable regional differences in survival.
Stensvold E; Myklebust TÅ; Cappelen J; Due-Tønnessen BJ; Due-Tønnessen P; Kepka A; Johannesen TB; Krossnes B; Lundar T; Maric S; Miletic H; Moholdt V; Myrmel KS; Nordberg T; Rydland J; Stokland T; Solem K; Solheim O; Torsvik I; Wikran GC; Zeller B; Wesenberg F; Bechensteen AG; Brandal P
Pediatr Blood Cancer; 2019 Oct; 66(10):e27910. PubMed ID: 31264356
[TBL] [Abstract][Full Text] [Related]
35. Foxr2 promotes formation of CNS-embryonal tumors in a Trp53-deficient background.
Poh B; Koso H; Momota H; Komori T; Suzuki Y; Yoshida N; Ino Y; Todo T; Watanabe S
Neuro Oncol; 2019 Aug; 21(8):993-1004. PubMed ID: 30976792
[TBL] [Abstract][Full Text] [Related]
36. Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system.
Yasuda K; Taguchi H; Sawamura Y; Ikeda J; Aoyama H; Fujieda K; Ishii N; Kashiwamura M; Iwasaki Y; Shirato H
Jpn J Clin Oncol; 2008 Jul; 38(7):486-92. PubMed ID: 18573848
[TBL] [Abstract][Full Text] [Related]
37. MEK Inhibitors Reverse Growth of Embryonal Brain Tumors Derived from Oligoneural Precursor Cells.
Modzelewska K; Boer EF; Mosbruger TL; Picard D; Anderson D; Miles RR; Kroll M; Oslund W; Pysher TJ; Schiffman JD; Jensen R; Jette CA; Huang A; Stewart RA
Cell Rep; 2016 Oct; 17(5):1255-1264. PubMed ID: 27783941
[TBL] [Abstract][Full Text] [Related]
38. The case for DNA methylation based molecular profiling to improve diagnostic accuracy for central nervous system embryonal tumors (not otherwise specified) in adults.
Halliday GC; Junckerstorff RC; Bentel JM; Miles A; Jones DTW; Hovestadt V; Capper D; Endersby R; Cole CH; van Hagen T; Gottardo NG
J Clin Neurosci; 2018 Jan; 47():163-167. PubMed ID: 28993028
[TBL] [Abstract][Full Text] [Related]
39. MRI Features of Histologically Diagnosed Supratentorial Primitive Neuroectodermal Tumors and Pineoblastomas in Correlation with Molecular Diagnoses and Outcomes: A Report from the Children's Oncology Group ACNS0332 Trial.
Jaju A; Hwang EI; Kool M; Capper D; Chavez L; Brabetz S; Billups C; Li Y; Fouladi M; Packer RJ; Pfister SM; Olson JM; Heier LA
AJNR Am J Neuroradiol; 2019 Nov; 40(11):1796-1803. PubMed ID: 31601576
[TBL] [Abstract][Full Text] [Related]
40. Evaluation and Diagnosis of Central Nervous System Embryonal Tumors (Non-Medulloblastoma).
Cotter JA; Judkins AR
Pediatr Dev Pathol; 2022; 25(1):34-45. PubMed ID: 35168419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
